Next Article in Journal
Association between Obstructive Sleep Apnea and Chronic Kidney Disease According to Sex, Long Working Hours: The Korean National Health and Nutrition Examination Survey (2019–2020)
Previous Article in Journal
The Cytotoxic Properties of Extreme Fungi’s Bioactive Components—An Updated Metabolic and Omics Overview
Previous Article in Special Issue
Treatment-Related Adverse Events with PD-1 or PD-L1 Inhibitors: A Systematic Review and Meta-Analysis
 
 
Correction to Life 2021, 11(8), 813.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Li et al. Novel Therapies for Tongue Squamous Cell Carcinoma Patients with High-Grade Tumors. Life 2021, 11, 813

1
Department of Oral and Maxillofacial Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
2
Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
3
School of Clinical Medicine, Baotou Medical College, Baotou 014040, China
*
Authors to whom correspondence should be addressed.
Life 2023, 13(8), 1624; https://doi.org/10.3390/life13081624
Submission received: 18 June 2023 / Accepted: 28 June 2023 / Published: 26 July 2023
(This article belongs to the Special Issue Molecular Mechanism and Therapeutic Effect of Drugs in Cancer)

Author Information Correction

  • Yinghua Li was not included as an author in the original publication [1]. With this correction, the order of affiliations has been adjusted accordingly. The corrected Author Contributions statement appears here:
    • Author Contributions: Y.L. and H.L. performed the study and wrote the manuscript. L.C. contributed to data analysis. Z.C. and W.L. performed the technical modification and conceived the study.
  • For authors Zihao Chen and Weizhong Li, the correct order as follows: Zihao Chen and Weizhong Li.
  • The authors want to add Weizhong Li as corresponding author, and change Weizhong Li’s email address to liwz@smu.edu.cn.

Affiliations Correction

In the published publication, there were errors regarding the affiliations 1–3. The updated affiliations should be:
1 
Department of Oral and Maxillofacial Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
2 
Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
3 
School of Clinical Medicine, Baotou Medical College, Baotou 014040, China
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Li, Y.; Lin, H.; Chen, L.; Chen, Z.; Li, W. Novel therapies for tongue squamous cell carcinoma patients with high-grade tumors. Life 2021, 11, 813. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, Y.; Lin, H.; Chen, L.; Chen, Z.; Li, W. Correction: Li et al. Novel Therapies for Tongue Squamous Cell Carcinoma Patients with High-Grade Tumors. Life 2021, 11, 813. Life 2023, 13, 1624. https://doi.org/10.3390/life13081624

AMA Style

Li Y, Lin H, Chen L, Chen Z, Li W. Correction: Li et al. Novel Therapies for Tongue Squamous Cell Carcinoma Patients with High-Grade Tumors. Life 2021, 11, 813. Life. 2023; 13(8):1624. https://doi.org/10.3390/life13081624

Chicago/Turabian Style

Li, Yinghua, Hao Lin, Lu Chen, Zihao Chen, and Weizhong Li. 2023. "Correction: Li et al. Novel Therapies for Tongue Squamous Cell Carcinoma Patients with High-Grade Tumors. Life 2021, 11, 813" Life 13, no. 8: 1624. https://doi.org/10.3390/life13081624

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop